Genetic Testing for Pancreatic Cancer

The comprehensive hereditary cancer panel screens for genetic variants most strongly associated with pancreatic cancer risk, so you and your family can take proactive steps toward better health.
By
Sharon Pollack, MS, CGC
This post was originally published in 2026, and last updated in July 2026.

Most people find out too late. You don't have to.

Pancreatic cancer rarely causes noticeable symptoms until it has spread. About 5-10% of cases are tied to hereditary gene mutations.¹ If an inherited gene change is driving your cancer risk, a hereditary cancer test can help you better understand that risk, giving you a powerful chance to act before symptoms start.

Knowing your inherited risk early means your doctor can put a monitoring plan in place, using imaging tools to catch cancers at early stages so they can be treated more effectively.

For people who've already been diagnosed, knowing your genetic mutations may also open the door to targeted treatment options.

Get started with hereditary cancer testing

Who Should Consider Hereditary Pancreatic Cancer Genetic Testing?

Pancreatic cancer is the third leading cause of cancer death in the US.² Knowing your inherited risk is one of the few ways to get ahead of it.

1.

Family History of Pancreatic Cancer

If a parent, sibling, or child has had pancreatic cancer, you may carry an inherited gene change that raises your own risk, and genetic testing is recommended.³

2.

Known BRCA or Lynch Syndrome Changes in the Family

People with gene changes linked to BRCA1, BRCA2, ATM, Lynch Syndrome and other cancer predisposition syndromes have a higher chance of developing pancreatic cancer, aside from other associated cancer risks.4,5,6

3.

Personal Pancreatic Cancer Diagnosis

If you've been diagnosed with pancreatic cancer, hereditary testing may reveal gene changes that affect your treatment options and help your family members understand their own risk.³

4.

Multiple Cancers Across Your Family

A pattern of breast, ovarian, pancreatic, prostate, stomach, and skin cancers, amongst others, especially across multiple generations, is a strong signal that an inherited syndrome may be at play, and that hereditary cancer testing may be valuable.⁷

5.

Ashkenazi Jewish Heritage

People of Ashkenazi Jewish descent carry BRCA1 and BRCA2 changes at a much higher rate than the general population. Both genes are linked to elevated pancreatic cancer risk.⁸

6.

Anyone Who Wants to Know Their Risk

You don't need a family history of cancer to benefit from testing. Many people choose hereditary cancer testing simply to understand their baseline risk and make informed decisions about their long-term health.

Key Genes Linked to Hereditary Pancreatic Cancer

Scientist in lab coat and gloves operating gene testing machines in a laboratory setting.

A comprehensive hereditary cancer panel analyzes the genes most strongly tied to inherited pancreatic cancer risk, including several often missed by narrower tests.

Full gene list available here. Results reviewed by board-certified genetic counselors.

Gene
Disease
BRCA2

Carriers have an estimated 5% to 10% lifetime risk overall.⁴

‍

ATM

Linked to an estimated 9.5% risk of pancreatic cancer by age 80, a level similar to BRCA2. ATM is also linked to breast and prostate cancer risk.⁵

‍

STK11

The gene behind Peutz-Jeghers Syndrome. Carriers face an 11% to 36% risk of pancreatic cancer.¹⁰

CDKN2A

Linked to familial pancreatic cancer and melanoma. Carriers face an estimated 15% or higher lifetime risk of pancreatic cancer, compared to under 2% in the general population.¹¹

BRCA1

Carries an estimated lifetime risk of up to 5% for pancreatic cancer, lower than BRCA2, but still clinically significant.⁴

PALB2

Works alongside BRCA2 to help repair DNA. Carriers have an estimated 5% to 10% risk of pancreatic cancer.⁹

TP53

Associated with Li-Fraumeni Syndrome. Pancreatic cancer is recognized as one of the cancers with elevated risk in TP53 carriers, alongside the syndrome's core cancers of breast, sarcoma, brain, and adrenal tissue.¹²

Other
Lynch
Syndrome
Genes

Other Lynch Syndrome genes’ mutations also increase pancreatic cancer risk to varying degrees

MLH1

A Lynch Syndrome gene tied to elevated pancreatic cancer risk, alongside colorectal, uterine, and other cancers. Research places the risk as high as an estimated 6% by age 75.⁶

How At-Home Genetic Testing Works

Order and register

Order your at-home genetic test and register online.

Collect your sample

Your sample collection kit should arrive 7–10 business days after registration.

Return your sample

Follow the instructions in the kit to collect and return your sample.

Get your results

Results are typically available 2-3 weeks after the sample reaches the lab.

Talk to a genetic counselor

You’ll have the opportunity to discuss your results with a genetic counselor.

Costs and Insurance Coverage

jscreen was established on a simple but deeply held belief: that everyone deserves access to testing that can protect themselves and their families from devastating genetic diseases. We're committed to working with you to ensure cost is never a barrier.

Insurance Billing

Most commercial insurance plans cover genetic testing for carrier screening and hereditary cancer testing. You'll receive a personalized cost estimate from our lab partner. Your final cost depends on your family history, specific insurance plan, deductible, and copay. Talk to your care navigator if you need financial assistance.

Self-Pay Option

jscreen offers genetic testing kits for a $249 flat fee (plus the $49 upfront fee, for a total of $298) if you choose not to use insurance or your insurance doesn't cover testing. You also have the option to switch from insurance coverage to self-pay once you receive your personalized estimate.

Get Tested Today

Join thousands of people who have used hereditary cancer testing to take a proactive step toward protecting their health and their family's future.
Get Started Today

References

  1. Ossowski S, et al. Current status of inherited pancreatic cancer. Hered Cancer Clin Pract. 2022;20(1):16. doi:10.1186/s13053-022-00224-2
  2. National Cancer Institute. Common cancer sites — cancer stat facts. Surveillance, Epidemiology, and End Results Program (SEER). Accessed July 11, 2026. https://seer.cancer.gov/statfacts/html/common.html
  3. Hirshberg Foundation for Pancreatic Cancer Research. Genetic counseling. Published January 2025. Accessed July 11, 2026. https://pancreatic.org/patients-caregivers/resources/genetic-counseling/
  4. National Cancer Institute. BRCA gene changes: cancer risk and genetic testing fact sheet. Accessed July 11, 2026. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet
  5. Klein AP, et al. Risk of pancreatic cancer among individuals with pathogenic variants in the ATM gene. JAMA Oncol. 2021;7(11):1722-1724. doi:10.1001/jamaoncol.2021.3780
  6. Nurmi A, et al. Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: a retrospective analysis from the Finnish National Lynch Syndrome Research Registry. Front Oncol. 2023;13:1123901. doi:10.3389/fonc.2023.1123901
  7. American Cancer Society. Hereditary breast and ovarian cancer syndrome (HBOC). Updated April 2026. Accessed July 11, 2026. https://www.cancer.org/cancer/risk-prevention/genetics/family-cancer-syndromes/hboc-hereditary-breast-and-ovarian-cancer-syndrome.html
  8. Pancreatic Cancer Action Network. Ashkenazi Jewish ancestry and pancreatic cancer risk. Published October 2024. Accessed July 11, 2026. https://pancan.org/news/ashkenazi-jewish-ancestry-and-pancreatic-cancer-risk/
  9. National Cancer Institute. PALB2 and Associated Cancer Risks (PDQ®). PDQ Cancer Information Summaries. National Center for Biotechnology Information; February 2025. Accessed July 11, 2026. https://www.ncbi.nlm.nih.gov/books/NBK609615/
  10. Cleveland Clinic. Peutz-Jeghers syndrome: what it is, symptoms & genetics. Updated April 2026. Accessed July 11, 2026. https://my.clevelandclinic.org/health/diseases/17362-peutz-jeghers-syndrome-pjs
  11. FORCE (Facing Our Risk of Cancer Empowered). Inherited CDKN2A mutation and cancer risk of pancreas and skin. Published November 2024. Accessed July 11, 2026. https://www.facingourrisk.org/XRAY/life-with-CDKN2A-a-high-risk-pancreatic-and-melanoma-mutation
  12. Schneider K, Zelley K, Nichols KE, Garber J. Li-Fraumeni syndrome. In: Adam MP, Feldman J, Mirzaa GM, et al, eds. GeneReviews®. University of Washington, Seattle; 1993-2026. Updated May 2025. Accessed July 11, 2026. https://www.ncbi.nlm.nih.gov/books/NBK1311/